Ullet index:KAKEN PHARMACEUTICAL CO.,LTD.:4521

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KAKEN PHARMACEUTICAL CO.,LTD. Go to web site 4521 Medicals 東証プライム March 1, 2000 1961.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

KAKEN PHARMACEUTICAL CO.,LTD. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 152,634
plusup
143,755
plusup
136,258
plusdown
137,747
plusup
136,257
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp 13,945
plusup
8,026
plusup
5,440
plusdown
9,549
plusdown
13,405
plus
Operating Cash Flow(OFC)Help 29,779
plusup
2,577
plusdown
9,253
plusdown
13,337
plusdown
14,379
plus
Free Cash Flow(FCF)Help 10,129
plusup
-3,277
plusdown
6,626
plusup
5,449
plusdown
12,735
plus
OFC - Net IncomeHelp 62
plusup
53
plusdown
54
plusdown
55
plusup
55
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp 40.47%
plusup
3.26%
plusdown
11.59%
plusdown
16.03%
plusdown
16.61%
plus
Current Assets / Amount of SalesHelp 78.26%
plusdown
109.80%
plusup
109.38%
plusdown
109.40%
plusdown
115.48%
plus
Free Cash Revenue RatioHelp 10.77%
plusup
-4.55%
plusdown
9.08%
plusup
7.17%
plusdown
16.98%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KAKEN PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

R-TECH UENO,LTD.
Chordia Therapeutics
Kidswell Bio Corporation
FunPep Company Limited
Immuno-Biological Laboratories Co., Ltd.
SAWAI PHARMACEUTICAL CO.,LTD.
Cyfuse Biomedical K.K.
Fuso Pharmaceutical Industries, Ltd.
Oncolys BioPharma Inc.
Veritas In Silico